Orionis Biosciences
About:
Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.
Website: http://orionisbio.com
Top Investors: Cormorant Asset Management, Novartis, Solasta Ventures, Excel Venture Management, Empire Angels
Description:
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation. The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initial internal focus in oncology and immunotherapies. Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.
$79.5M
$1M to $10M
Boston, Massachusetts, United States
2015-01-01
Nikolai Kley
11-50
2022-10-19
Private
© 2025 bioDAO.ai